Boehringer Ingelheim Jascayd tablets approved by USFDA for idiopathic pulmonary fibrosis
- 14 October 2025
- 1 week ago
Boehringer Ingelheim, 3T Biosciences Enter Into Second Partnership For Cancer Immunotherapies
- 28 July 2025
- 2 months ago
Recent News
Avalanche Safety Device Shown to Delay Hypoxemia a...
- 23 October, 2025
Health Ministry Proposes Barcoding Rule for All Va...
- 23 October, 2025
Boehringer Ingelheim Jascayd gets nod in China for...
- 23 October, 2025
Mizoram reports 121 multidrug-resistant TB Deaths...
- 23 October, 2025
GSK Shingrix new prefilled syringe presentation ge...
- 23 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.


